0001209191-22-009063.txt : 20220214 0001209191-22-009063.hdr.sgml : 20220214 20220214100949 ACCESSION NUMBER: 0001209191-22-009063 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 EFFECTIVENESS DATE: 20220214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Silver Creek Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001691988 IRS NUMBER: 272937876 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-433467 FILM NUMBER: 22626595 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-2178 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0708 D LIVE 0001691988 Silver Creek Pharmaceuticals, Inc. 409 Illinois Street San Francisco CA CALIFORNIA 94158 415-978-2178 DELAWARE None None Corporation true Timothy Throsby 409 Illinois Street San Francisco CA CALIFORNIA 94158 Executive Officer Director Mark Agne 409 Illinois Street San Francisco CA CALIFORNIA 94158 Director Thomas J. Murtagh 409 Illinois Street San Francisco CA CALIFORNIA 94158 Director Nick Taylor 409 Illinois Street San Francisco CA CALIFORNIA 94158 Director James D. Marks 409 Illinois Street San Francisco CA CALIFORNIA 94158 Director Lakhmir Chawla 409 Illinois Street San Francisco CA CALIFORNIA 94158 Executive Officer Kris Kuchenbecker 409 Illinois Street San Francisco CA CALIFORNIA 94158 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2022-01-31 false true true false 0 25000000 9150000 15850000 The Issuer is offering up to $25,000,000 in principal amount of convertible promissory notes. This Form D is also intended to cover the underlying equity securities. false 22 0 0 0 false Silver Creek Pharmaceuticals, Inc. /s/ Timothy Throsby Timothy Throsby Chariman 2022-02-11